|
Dec 22
|
WAINUA™ (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
|
|
Dec 21
|
CORRECTED-UPDATE 2-US FDA approves Ionis-AstraZeneca's nerve disease drug
|
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|
|
Dec 19
|
13 Most Promising Healthcare Stocks According to Analysts
|
|
Dec 19
|
Ionis (IONS) Out Licenses Europe Rights for HAE Drug to Otsuka
|
|
Dec 19
|
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
|
|
Dec 18
|
Astrazeneca (AZN) Exceeds Market Returns: Some Facts to Consider
|
|
Dec 18
|
11 Best European Dividend Stocks to Buy
|
|
Dec 18
|
13 Most Profitable Pharmaceutical Stocks Now
|
|
Dec 10
|
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?
|
|
Dec 10
|
Is Now the Right Time to Buy AstraZeneca Stock?
|
|
Dec 7
|
UPDATE 2-US urges makers of infant RSV shots to meet winter demand
|
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
|
Dec 6
|
Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas
|
|
Dec 5
|
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Dec 5
|
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
|
|
Dec 5
|
These 3 stocks are Cowen’s best ideas for 2024 including AstraZeneca and Datadog
|
|
Dec 4
|
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca
|
|
Dec 3
|
AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT
|
|
Dec 3
|
UPDATE 1-AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT
|